Q32 Bio (QTTB) Non-Current Assets (2017 - 2026)

Q32 Bio's Non-Current Assets history runs 10 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 37.99% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $28.0 million (down 36.62% YoY), while the FY2025 annual figure was $6.7 million, down 35.67% from the prior year.
• Non-Current Assets was $6.5 million for Q1 2026 at Q32 Bio, down from $6.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $228.7 million in Q4 2022 to a low of $6.5 million in Q1 2026.
• Historically, Non-Current Assets has averaged $38.2 million across 5 years, with a median of $14.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 1054.58% in 2022, then tumbled 85.96% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $228.7 million in 2022, then plunged by 67.45% to $74.5 million in 2023, then sank by 85.96% to $10.5 million in 2024, then plunged by 35.67% to $6.7 million in 2025, then retreated by 3.76% to $6.5 million in 2026.
• The last three Non-Current Assets figures came in at $6.5 million (Q1 2026), $6.7 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.